Molecular basis for sequence-specific DNA alkylation by CC-1065
Authors:
- Chong Soon LeeCLChong Soon Lee
- J. Patrick McGovrenJMJ. Patrick McGovren
- Martha A. WarpehoskiMWMartha A. Warpehoski
- Mark A. MitchellMMMark A. Mitchell
- Robert C. KellyRKRobert C. Kelly
- Paul A. AristoffPAPaul A. Aristoff
- 1 May 1988
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 27 (10) , 3886-3892
Abstract
Note: In lieu of an abstract, this is the article's first page.Keywords
This publication has 16 references indexed in Scilit:
- DNA sequence specificity of the pyrrolo[1,4]benzodiazepine antitumor antibiotics. Methidiumpropyl-EDTA-iron(II) footprinting analysis of DNA binding sites for anthramycin and related drugsBiochemistry, 1986
- Reaction of the antitumor antibiotic CC-1065 with DNA. Location of the site of thermally induced strand breakage and analysis of DNA sequence specificityBiochemistry, 1985
- Binding of CC‐1065 to poly‐ and oligonucleotidesBiopolymers, 1985
- The molecular origin of DNA-drug specificity in netropsin and distamycin.Proceedings of the National Academy of Sciences, 1985
- Reaction of the Antitumor Antibiotic CC-1065 with DNA: Structure of a DNA Adduct with DNA Sequence SpecificityScience, 1984
- Preliminary toxicity studies with the DNA-binding antibiotic, CC-1065.The Journal of Antibiotics, 1984
- Sequence specificity in aflatoxin B1--DNA interactions.Proceedings of the National Academy of Sciences, 1983
- CC-1065 (NSC-298223), A MOST POTENT ANTI-TUMOR AGENT - KINETICS OF INHIBITION OF GROWTH, DNA-SYNTHESIS, AND CELL-SURVIVAL1982
- CC-1065(NSC 298223), a potent new antitumor agent. Improved production and isolation, characterization and antitumor activity.The Journal of Antibiotics, 1981
- CC-1065 (NSC-298223), a new antitumor antibiotic. Production, in vitro biological activity, microbiological assays and taxonomy of the producing microorganism.The Journal of Antibiotics, 1978